CRINETICS PHARMACEUTICALS IN's ticker is CRNX and the CUSIP is 22663K107. A total of 116 filers reported holding CRINETICS PHARMACEUTICALS IN in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,594,153 | +133.7% | 53,603 | +41.6% | 0.00% | – |
| Q2 2023 | $682,020 | +88.3% | 37,848 | +67.9% | 0.00% | – |
| Q1 2023 | $362,104 | +24.1% | 22,547 | +41.4% | 0.00% | – |
| Q4 2022 | $291,812 | -2.7% | 15,946 | +4.5% | 0.00% | – |
| Q3 2022 | $300,000 | +11.5% | 15,261 | +5.8% | 0.00% | – |
| Q2 2022 | $269,000 | -14.1% | 14,430 | +1.3% | 0.00% | – |
| Q1 2022 | $313,000 | -20.4% | 14,241 | +2.8% | 0.00% | – |
| Q4 2021 | $393,000 | +94.6% | 13,851 | +44.6% | 0.00% | – |
| Q3 2021 | $202,000 | +110.4% | 9,576 | +88.0% | 0.00% | – |
| Q2 2021 | $96,000 | +50.0% | 5,093 | +20.3% | 0.00% | – |
| Q1 2021 | $64,000 | +12.3% | 4,235 | +5.7% | 0.00% | – |
| Q4 2020 | $57,000 | -9.5% | 4,005 | 0.0% | 0.00% | – |
| Q3 2020 | $63,000 | -30.0% | 4,005 | -21.9% | 0.00% | – |
| Q2 2020 | $90,000 | +221.4% | 5,129 | +174.0% | 0.00% | – |
| Q1 2020 | $28,000 | -48.1% | 1,872 | -17.2% | 0.00% | – |
| Q4 2019 | $54,000 | +92.9% | 2,262 | +22.7% | 0.00% | – |
| Q3 2019 | $28,000 | -39.1% | 1,843 | 0.0% | 0.00% | – |
| Q2 2019 | $46,000 | +39.4% | 1,843 | +26.0% | 0.00% | – |
| Q1 2019 | $33,000 | +6.5% | 1,463 | +38.9% | 0.00% | – |
| Q4 2018 | $31,000 | +3.3% | 1,053 | 0.0% | 0.00% | – |
| Q3 2018 | $30,000 | – | 1,053 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Saturn V Capital Management LP | 1,126,579 | $33,504,459 | 14.02% |
| New Leaf Venture Partners, L.L.C. | 141,000 | $4,193,340 | 5.38% |
| First Light Asset Management, LLC | 1,583,329 | $47,088,204 | 4.47% |
| Paradigm Biocapital Advisors LP | 2,178,737 | $64,795,638 | 4.40% |
| Bain Capital Life Sciences Investors, LLC | 1,275,552 | $37,934,916 | 4.24% |
| Altium Capital Management LP | 262,000 | $7,791,880 | 4.06% |
| 5AM Venture Management, LLC | 462,286 | $13,748,386 | 3.96% |
| MPM BioImpact LLC | 479,053 | $14,247,036 | 3.80% |
| Affinity Asset Advisors, LLC | 450,000 | $13,383,000 | 3.76% |
| Opaleye Management Inc. | 370,000 | $11,003,800 | 3.58% |